Pharmaids Pharmaceuticals Surges to All-Time High, Outperforms Sector and Sensex
Pharmaids Pharmaceuticals, a microcap pharmaceutical company, has seen a remarkable 153.88% increase in stock returns over the past 11 days, reaching an all-time high of Rs.87.46 on November 13th, 2024. Despite a 'Strong Sell' rating from MarketsMojo, the stock has outperformed the sector and is trading above all its moving averages. It has also shown a significant increase in performance compared to the Sensex.
Pharmaids Pharmaceuticals, a microcap pharmaceutical company, has recently reached an all-time high stock price of Rs.87.46 on November 13th, 2024. This comes after the stock has been gaining for the past 11 consecutive days, with a remarkable 153.88% increase in returns during this period.
According to MarketsMOJO, a leading stock market analysis platform, the stock has been given a 'Strong Sell' rating. However, Pharmaids Pharmaceuticals has outperformed the sector by 4.99% today and opened with a gain of 4.99%. The stock also touched an intraday high of Rs.87.46, with no range in its trading price since opening.
In terms of moving averages, Pharmaids Pharmaceuticals is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock performance.
In comparison to the Sensex, Pharmaids Pharmaceuticals has shown a significant 95.67% increase in performance over the past year, while the Sensex has only seen a 21.09% increase.
Pharmaids Pharmaceuticals is a microcap company in the pharmaceutical industry. With its recent surge in stock price and positive performance indicators, it will be interesting to see how the company continues to grow and evolve in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
